AtriCure/$ATRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AtriCure
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Ticker
$ATRC
Sector
Primary listing
Employees
1,350
Headquarters
Website
AtriCure Metrics
BasicAdvanced
$2bn
190.44
$0.21
1.25
-
Price and volume
Market cap
$2bn
Beta
1.25
52-week high
$43.18
52-week low
$25.36
Average daily volume
1.1m
Financial strength
Current ratio
4.218
Quick ratio
3.025
Long term debt to equity
13.757
Total debt to equity
14.372
Interest coverage (TTM)
2.29%
Profitability
EBITDA (TTM)
33.712
Gross margin (TTM)
76.30%
Net profit margin (TTM)
1.85%
Operating margin (TTM)
2.26%
Effective tax rate (TTM)
12.75%
Revenue per employee (TTM)
$420,000
Management effectiveness
Return on assets (TTM)
1.25%
Return on equity (TTM)
2.15%
Valuation
Price to earnings (TTM)
190.435
Price to revenue (TTM)
3.399
Price to book
3.78
Price to tangible book (TTM)
8.2
Price to free cash flow (TTM)
37.152
Free cash flow yield (TTM)
2.69%
Free cash flow per share (TTM)
1.081
Growth
Revenue change (TTM)
13.94%
Earnings per share change (TTM)
-127.45%
3-year revenue growth (CAGR)
15.92%
10-year revenue growth (CAGR)
14.86%
3-year earnings per share growth (CAGR)
-29.94%
10-year earnings per share growth (CAGR)
-15.67%
What the Analysts think about AtriCure
Analyst ratings (Buy, Hold, Sell) for AtriCure stock.
AtriCure Financial Performance
Revenues and expenses
AtriCure Earnings Performance
Company profitability
AtriCure News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.